Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akito Hata

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2022
Histologic transformation of epidermal growth factor receptor-mutated lung cancerDaichi Fujimoto, Hiroaki Akamatsu, Takeshi Morimoto, et al.
Therapeutic Advances in Medical Oncology|February 17, 2025
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA studyShigeru Tanzawa, Hiroshige Yoshioka, Toshihiro Misumi, et al.
JTO Clinical and Research Reports|December 4, 2023
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA StudyYasunori Murata, Shigeru Tanzawa, Toshihiro Misumi, et al.
Journal of Medicinal Chemistry|May 18, 2021
Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous RouteStepan Vyskocil, David Cardin, Jeffrey Ciavarri, et al.
Therapeutic Advances in Medical Oncology|June 19, 2025
Ramucirumab and erlotinib combination as first-line treatment for advanced or recurrent non-small cell lung cancer harboring <i>EGFR</i> Exon21 L858R mutation: a multicenter retrospective observational cohort study in Japan (REAL-SPEED)Masashi Ishihara, Takahisa Kawamura, Yukiko Namba, et al.
JTO Clinical and Research Reports|April 6, 2026
Efficacy and Safety of First-Line Ramucirumab Plus Erlotinib for <i>EGFR</i> L858R-Mutated NSCLC in Real-World Practice: A Retrospective Multicenter REAL-SPEED AnalysisMasashi Ishihara, Takahisa Kawamura, Yukiko Namba, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2022
Histologic transformation of epidermal growth factor receptor-mutated lung cancerDaichi Fujimoto, Hiroaki Akamatsu, Takeshi Morimoto, et al.
Therapeutic Advances in Medical Oncology|February 17, 2025
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA studyShigeru Tanzawa, Hiroshige Yoshioka, Toshihiro Misumi, et al.
JTO Clinical and Research Reports|December 4, 2023
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA StudyYasunori Murata, Shigeru Tanzawa, Toshihiro Misumi, et al.
Journal of Medicinal Chemistry|May 18, 2021
Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous RouteStepan Vyskocil, David Cardin, Jeffrey Ciavarri, et al.
Therapeutic Advances in Medical Oncology|June 19, 2025
Ramucirumab and erlotinib combination as first-line treatment for advanced or recurrent non-small cell lung cancer harboring <i>EGFR</i> Exon21 L858R mutation: a multicenter retrospective observational cohort study in Japan (REAL-SPEED)Masashi Ishihara, Takahisa Kawamura, Yukiko Namba, et al.
JTO Clinical and Research Reports|April 6, 2026
Efficacy and Safety of First-Line Ramucirumab Plus Erlotinib for <i>EGFR</i> L858R-Mutated NSCLC in Real-World Practice: A Retrospective Multicenter REAL-SPEED AnalysisMasashi Ishihara, Takahisa Kawamura, Yukiko Namba, et al.
Pageof 15